Candriam SCA’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-310,000
Closed -$4.12M 733
2024
Q1
$4.12M Hold
310,000
0.03% 376
2023
Q4
$4.32M Buy
+310,000
New +$4.32M 0.03% 348
2023
Q2
Sell
-25,547
Closed -$339K 868
2023
Q1
$339K Buy
+25,547
New +$339K ﹤0.01% 845